Skip to main content
OpenTrials

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

2,767 public trials 494 recruiting studies
Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Active, Not Recruiting

Treating Patients With Melanoma and ALK Alterations With Ensartinib

NCT03420508

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
  • Memorial Sloan Kettering Westchester East White Plains, New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Active, Not Recruiting

Testing the Addition of an Anticancer Drug, Olaparib, to the Usual Chemotherapy (Temozolomide) for Advanced Neuroendocrine Cancer

NCT04394858

Conditions
Advanced Adrenal Gland Pheochromocytoma, Advanced Paraganglioma, Metastatic Adrenal Gland Pheochromocytoma, +13 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 163 locations
View Trial Details
Active, Not Recruiting

National Cancer Institute "Cancer Moonshot Biobank"

NCT04314401

Conditions
Acute Myeloid Leukemia, Adnexal Diseases, Anatomic Stage III Breast Cancer AJCC v8, +98 more
Locations
  • Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis Daphne, Alabama, United States
  • Thomas Hospital Fairhope, Alabama, United States
  • Mobile Infirmary Medical Center Mobile, Alabama, United States
  • Gulf Health Hospitals Inc/Infirmary Cancer Care - Saraland Saraland, Alabama, United States
View all 150 locations
View Trial Details
Active, Not Recruiting

A Study to Investigate the Antitumor Activity, Safety, Tolerability, and Pharmacokinetics of BGB-A445 in Combination With Tislelizumab in Participants With Select Advanced Solid Tumors.

NCT05661955

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +26 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Fujian Cancer Hospital Fuzhou, Fujian, China
  • The Second Hospital and Clinical Medical School, Lanzhou University Lanzhou, Gansu, China
  • Zhujiang Hospital of Southern Medical University Guangzhou, Guangdong, China
View all 18 locations
View Trial Details
Active, Not Recruiting

Study to Evaluate Adverse Events, Change in Disease Activity, and How ABBV-706 Moves Through the Body When Intravenously (IV) Infused Alone or in Combination With IV Infused Budigalimab, Cisplatin, or Carboplatin in Adult Participants With Advanced Solid Tumors

NCT05599984

Conditions
Adenocarcinoma, Advanced Solid Tumors, Bronchial Neoplasms, +20 more
Locations
  • Banner MD Anderson Cancer Ctr /ID# 260129 Gilbert, Arizona, United States
  • City Of Hope Comprehensive Cancer Center /ID# 271295 Duarte, California, United States
  • City of Hope - Orange County Lennar Foundation Cancer Center /ID# 259884 Irvine, California, United States
  • Yale New Haven Hospital /ID# 246647 New Haven, Connecticut, United States
View all 66 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate Adaptive Dosing of Ipilimumab and Nivolumab Combination Immunotherapy

NCT03122522

Conditions
Melanoma, Metastatic Melanoma, Neoplasms, +10 more
Locations
  • Hartford Healthcare Alliance (Data Collection Only) Hartford, Connecticut, United States
  • Jaykumar Thumar Hartford, Connecticut, United States
  • JOHNS HOPKINS HOSPITAL (Data Analysis Only) Baltimore, Maryland, United States
  • Brigham and Women's Hospital (Data and Specimen Analysis Only) Boston, Massachusetts, United States
View all 14 locations
View Trial Details

Related conditions